Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-014326
Filing Date
2024-11-05
Accepted
2024-11-05 07:15:37
Documents
5
Period of Report
2024-11-05

Document Format Files

Seq Description Document Type Size
1 6-K aciu-20241105x6k.htm 6-K 25956
2 EX-99.1 aciu-20241105xex99d1.htm EX-99.1 677863
3 EX-99.2 aciu-20241105xex99d2.htm EX-99.2 291731
4 EX-99.3 aciu-20241105xex99d3.htm EX-99.3 210457
5 GRAPHIC aciu-20241105xex99d3001.jpg GRAPHIC 3076
  Complete submission text file 0001558370-24-014326.txt   1211459
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 241425617
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)